|
1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL
|
DB07756 |
|
|
(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
|
DB07757 |
|
|
5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID
|
DB07758 |
|
|
5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID
|
DB07759 |
|
|
Talnetant
|
DB06429 |
[Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.] |
|
(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol
|
DB07750 |
|
|
(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol
|
DB07751 |
|
|
Endostatin
|
DB06423 |
|
|
Ticalopride
|
DB06422 |
|
|
Epibatidine
|
DB07720 |
|
|
DIETHYL 4-METHOXYPHENYL PHOSPHATE
|
DB07721 |
|
|
3-(4-NITRO-PHENOXY)-PROPAN-1-OL
|
DB07722 |
|
|
3-(5-methoxy-1H-indol-3-yl)propanoic acid
|
DB07723 |
|
|
Indeglitazar
|
DB07724 |
|
|
2-tert-butylbenzene-1,4-diol
|
DB07726 |
|
|
2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
|
DB07728 |
|
|
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide
|
DB07729 |
|
|
4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL
|
DB07731 |
|
|
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE
|
DB07732 |
|
|
1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
|
DB07733 |
|
